Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2001 Dec;109(12):1215–1226. doi: 10.1289/ehp.011091215

Assessing the public health benefits of reduced ozone concentrations.

J I Levy 1, T J Carrothers 1, J T Tuomisto 1, J K Hammitt 1, J S Evans 1
PMCID: PMC1240503  PMID: 11748028

Abstract

In this paper we examine scientific evidence and related uncertainties in two steps of benefit-cost analyses of ozone reduction: estimating the health improvements attributable to reductions in ozone and determining the appropriate monetary values of these improvements. Although substantial evidence exists on molecular and physiologic impacts, the evidence needed to establish concentration-response functions is somewhat limited. Furthermore, because exposure to ozone depends on factors such as air conditioning use, past epidemiologic studies may not be directly applicable in unstudied settings. To evaluate the evidence likely to contribute significantly to benefits, we focus on four health outcomes: premature mortality, chronic asthma, respiratory hospital admissions, and minor restricted activity days. We determine concentration-response functions for these health outcomes for a hypothetical case study in Houston, Texas, using probabilistic weighting reflecting our judgment of the strength of the evidence and the possibility of confounding. We make a similar presentation for valuation, where uncertainty is due primarily to the lack of willingness-to-pay data for the population affected by ozone. We estimate that the annual monetary value of health benefits from reducing ozone concentrations in Houston is approximately $10 per person per microgram per cubic meter (24-hr average) reduced (95% confidence interval, $0.70-$40). The central estimate exceeds past estimates by approximately a factor of five, driven by the inclusion of mortality. We discuss the implications of our findings for future analyses and determine areas of research that might help reduce the uncertainties in benefit estimation.

Full Text

The Full Text of this article is available as a PDF (569.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbey D. E., Nishino N., McDonnell W. F., Burchette R. J., Knutsen S. F., Lawrence Beeson W., Yang J. X. Long-term inhalable particles and other air pollutants related to mortality in nonsmokers. Am J Respir Crit Care Med. 1999 Feb;159(2):373–382. doi: 10.1164/ajrccm.159.2.9806020. [DOI] [PubMed] [Google Scholar]
  2. Arthur W. B. The economics of risks to life. Am Econ Rev. 1981 Mar;71(1):54–64. [PubMed] [Google Scholar]
  3. Beaty T. H., Newill C. A., Cohen B. H., Tockman M. S., Bryant S. H., Spurgeon H. A. Effects of pulmonary function on mortality. J Chronic Dis. 1985;38(8):703–710. doi: 10.1016/0021-9681(85)90024-4. [DOI] [PubMed] [Google Scholar]
  4. Blumenschein K., Johannesson M. Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma. Ann Allergy Asthma Immunol. 1998 Feb;80(2):189–194. doi: 10.1016/S1081-1206(10)62954-7. [DOI] [PubMed] [Google Scholar]
  5. Burnett R. T., Dales R. E., Brook J. R., Raizenne M. E., Krewski D. Association between ambient carbon monoxide levels and hospitalizations for congestive heart failure in the elderly in 10 Canadian cities. Epidemiology. 1997 Mar;8(2):162–167. doi: 10.1097/00001648-199703000-00007. [DOI] [PubMed] [Google Scholar]
  6. Burnett R. T., Smith-Doiron M., Stieb D., Cakmak S., Brook J. R. Effects of particulate and gaseous air pollution on cardiorespiratory hospitalizations. Arch Environ Health. 1999 Mar-Apr;54(2):130–139. doi: 10.1080/00039899909602248. [DOI] [PubMed] [Google Scholar]
  7. Chang L. Y., Huang Y., Stockstill B. L., Graham J. A., Grose E. C., Menache M. G., Miller F. J., Costa D. L., Crapo J. D. Epithelial injury and interstitial fibrosis in the proximal alveolar regions of rats chronically exposed to a simulated pattern of urban ambient ozone. Toxicol Appl Pharmacol. 1992 Aug;115(2):241–252. doi: 10.1016/0041-008X(92)90329-Q. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986 Sep;7(3):177–188. doi: 10.1016/0197-2456(86)90046-2. [DOI] [PubMed] [Google Scholar]
  9. Dockery D. W., Pope C. A., 3rd Acute respiratory effects of particulate air pollution. Annu Rev Public Health. 1994;15:107–132. doi: 10.1146/annurev.pu.15.050194.000543. [DOI] [PubMed] [Google Scholar]
  10. Dockery D. W., Pope C. A., 3rd, Xu X., Spengler J. D., Ware J. H., Fay M. E., Ferris B. G., Jr, Speizer F. E. An association between air pollution and mortality in six U.S. cities. N Engl J Med. 1993 Dec 9;329(24):1753–1759. doi: 10.1056/NEJM199312093292401. [DOI] [PubMed] [Google Scholar]
  11. Dockery D. W., Schwartz J., Spengler J. D. Air pollution and daily mortality: associations with particulates and acid aerosols. Environ Res. 1992 Dec;59(2):362–373. doi: 10.1016/s0013-9351(05)80042-8. [DOI] [PubMed] [Google Scholar]
  12. Dudley S. E., Gramm W. L. EPA's ozone standard may harm public health and welfare. Risk Anal. 1997 Aug;17(4):403–405. doi: 10.1111/j.1539-6924.1997.tb00880.x. [DOI] [PubMed] [Google Scholar]
  13. Fairley D. Daily mortality and air pollution in Santa Clara County, California: 1989-1996. Environ Health Perspect. 1999 Aug;107(8):637–641. doi: 10.1289/ehp.99107637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Folinsbee L. J., McDonnell W. F., Horstman D. H. Pulmonary function and symptom responses after 6.6-hour exposure to 0.12 ppm ozone with moderate exercise. JAPCA. 1988 Jan;38(1):28–35. doi: 10.1080/08940630.1988.10466349. [DOI] [PubMed] [Google Scholar]
  15. Gwynn R. C., Burnett R. T., Thurston G. D. A time-series analysis of acidic particulate matter and daily mortality and morbidity in the Buffalo, New York, region. Environ Health Perspect. 2000 Feb;108(2):125–133. doi: 10.1289/ehp.00108125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. HILL A. B. THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION? Proc R Soc Med. 1965 May;58:295–300. doi: 10.1177/003591576505800503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Harkema J. R., Plopper C. G., Hyde D. M., St George J. A., Wilson D. W., Dungworth D. L. Response of macaque bronchiolar epithelium to ambient concentrations of ozone. Am J Pathol. 1993 Sep;143(3):857–866. [PMC free article] [PubMed] [Google Scholar]
  18. Hazucha M. J., Bates D. V., Bromberg P. A. Mechanism of action of ozone on the human lung. J Appl Physiol (1985) 1989 Oct;67(4):1535–1541. doi: 10.1152/jappl.1989.67.4.1535. [DOI] [PubMed] [Google Scholar]
  19. Hoek G., Schwartz J. D., Groot B., Eilers P. Effects of ambient particulate matter and ozone on daily mortality in Rotterdam, The Netherlands. Arch Environ Health. 1997 Nov-Dec;52(6):455–463. doi: 10.1080/00039899709602224. [DOI] [PubMed] [Google Scholar]
  20. Hole D. J., Watt G. C., Davey-Smith G., Hart C. L., Gillis C. R., Hawthorne V. M. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ. 1996 Sep 21;313(7059):711–716. doi: 10.1136/bmj.313.7059.711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Horstman D. H., Folinsbee L. J., Ives P. J., Abdul-Salaam S., McDonnell W. F. Ozone concentration and pulmonary response relationships for 6.6-hour exposures with five hours of moderate exercise to 0.08, 0.10, and 0.12 ppm. Am Rev Respir Dis. 1990 Nov;142(5):1158–1163. doi: 10.1164/ajrccm/142.5.1158. [DOI] [PubMed] [Google Scholar]
  22. Ito K., Thurston G. D. Daily PM10/mortality associations: an investigations of at-risk subpopulations. J Expo Anal Environ Epidemiol. 1996 Jan-Mar;6(1):79–95. [PubMed] [Google Scholar]
  23. Jamason P. F., Kalkstein L. S., Gergen P. J. A synoptic evaluation of asthma hospital admissions in New York City. Am J Respir Crit Care Med. 1997 Dec;156(6):1781–1788. doi: 10.1164/ajrccm.156.6.96-05028. [DOI] [PubMed] [Google Scholar]
  24. Kalkstein L. S., Greene J. S. An evaluation of climate/mortality relationships in large U.S. cities and the possible impacts of a climate change. Environ Health Perspect. 1997 Jan;105(1):84–93. doi: 10.1289/ehp.9710584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kelsall J. E., Samet J. M., Zeger S. L., Xu J. Air pollution and mortality in Philadelphia, 1974-1988. Am J Epidemiol. 1997 Nov 1;146(9):750–762. doi: 10.1093/oxfordjournals.aje.a009351. [DOI] [PubMed] [Google Scholar]
  26. Kinney P. L., Thurston G. D., Raizenne M. The effects of ambient ozone on lung function in children: a reanalysis of six summer camp studies. Environ Health Perspect. 1996 Feb;104(2):170–174. doi: 10.1289/ehp.96104170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Korrick S. A., Neas L. M., Dockery D. W., Gold D. R., Allen G. A., Hill L. B., Kimball K. D., Rosner B. A., Speizer F. E. Effects of ozone and other pollutants on the pulmonary function of adult hikers. Environ Health Perspect. 1998 Feb;106(2):93–99. doi: 10.1289/ehp.9810693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Lange P., Nyboe J., Appleyard M., Jensen G., Schnohr P. Spirometric findings and mortality in never-smokers. J Clin Epidemiol. 1990;43(9):867–873. doi: 10.1016/0895-4356(90)90070-6. [DOI] [PubMed] [Google Scholar]
  29. Larsen U. The effects of monthly temperature fluctuations on mortality in the United States from 1921 to 1985. Int J Biometeorol. 1990 Dec;34(3):136–145. doi: 10.1007/BF01048710. [DOI] [PubMed] [Google Scholar]
  30. Last J. A., Gelzleichter T., Harkema J., Parks W. C., Mellick P. Effects of 20 months of ozone exposure on lung collagen in Fischer 344 rats. Toxicology. 1993 Nov 12;84(1-3):83–102. doi: 10.1016/0300-483x(93)90110-e. [DOI] [PubMed] [Google Scholar]
  31. Levy J. I., Hammitt J. K., Spengler J. D. Estimating the mortality impacts of particulate matter: what can be learned from between-study variability? Environ Health Perspect. 2000 Feb;108(2):109–117. doi: 10.1289/ehp.00108109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Liu L. J., Delfino R., Koutrakis P. Ozone exposure assessment in a southern California community. Environ Health Perspect. 1997 Jan;105(1):58–65. doi: 10.1289/ehp.9710558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Mar T. F., Norris G. A., Koenig J. Q., Larson T. V. Associations between air pollution and mortality in Phoenix, 1995-1997. Environ Health Perspect. 2000 Apr;108(4):347–353. doi: 10.1289/ehp.00108347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Mariassy A. T., Abraham W. M., Phipps R. J., Sielczak M. W., Wanner A. Effect of ozone on the postnatal development of lamb mucociliary apparatus. J Appl Physiol (1985) 1990 Jun;68(6):2504–2510. doi: 10.1152/jappl.1990.68.6.2504. [DOI] [PubMed] [Google Scholar]
  35. McDonnell W. F., Abbey D. E., Nishino N., Lebowitz M. D. Long-term ambient ozone concentration and the incidence of asthma in nonsmoking adults: the AHSMOG Study. Environ Res. 1999 Feb;80(2 Pt 1):110–121. doi: 10.1006/enrs.1998.3894. [DOI] [PubMed] [Google Scholar]
  36. Moolgavkar S. H. Air pollution and daily mortality in three U.S. counties. Environ Health Perspect. 2000 Aug;108(8):777–784. doi: 10.1289/ehp.00108777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Moolgavkar S. H., Luebeck E. G. A critical review of the evidence on particulate air pollution and mortality. Epidemiology. 1996 Jul;7(4):420–428. doi: 10.1097/00001648-199607000-00014. [DOI] [PubMed] [Google Scholar]
  38. Moolgavkar S. H., Luebeck E. G., Hall T. A., Anderson E. L. Air pollution and daily mortality in Philadelphia. Epidemiology. 1995 Sep;6(5):476–484. doi: 10.1097/00001648-199509000-00003. [DOI] [PubMed] [Google Scholar]
  39. Mudway I. S., Kelly F. J. Ozone and the lung: a sensitive issue. Mol Aspects Med. 2000 Feb-Apr;21(1-2):1–48. doi: 10.1016/s0098-2997(00)00003-0. [DOI] [PubMed] [Google Scholar]
  40. O'Conor R. M., Blomquist G. C. Measurement of consumer-patient preferences using a hybrid contingent valuation method. J Health Econ. 1997 Dec;16(6):667–683. doi: 10.1016/s0167-6296(97)80198-1. [DOI] [PubMed] [Google Scholar]
  41. Ostro B. D., Rothschild S. Air pollution and acute respiratory morbidity: an observational study of multiple pollutants. Environ Res. 1989 Dec;50(2):238–247. doi: 10.1016/s0013-9351(89)80004-0. [DOI] [PubMed] [Google Scholar]
  42. Passannante A. N., Hazucha M. J., Bromberg P. A., Seal E., Folinsbee L., Koch G. Nociceptive mechanisms modulate ozone-induced human lung function decrements. J Appl Physiol (1985) 1998 Nov;85(5):1863–1870. doi: 10.1152/jappl.1998.85.5.1863. [DOI] [PubMed] [Google Scholar]
  43. Peters J. M., Avol E., Navidi W., London S. J., Gauderman W. J., Lurmann F., Linn W. S., Margolis H., Rappaport E., Gong H. A study of twelve Southern California communities with differing levels and types of air pollution. I. Prevalence of respiratory morbidity. Am J Respir Crit Care Med. 1999 Mar;159(3):760–767. doi: 10.1164/ajrccm.159.3.9804143. [DOI] [PubMed] [Google Scholar]
  44. Pinkerton K. E., Dodge D. E., Cederdahl-Demmler J., Wong V. J., Peake J., Haselton C. J., Mellick P. W., Singh G., Plopper C. G. Differentiated bronchiolar epithelium in alveolar ducts of rats exposed to ozone for 20 months. Am J Pathol. 1993 Mar;142(3):947–956. [PMC free article] [PubMed] [Google Scholar]
  45. Pope C. A., 3rd, Bates D. V., Raizenne M. E. Health effects of particulate air pollution: time for reassessment? Environ Health Perspect. 1995 May;103(5):472–480. doi: 10.1289/ehp.95103472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Pope C. A., 3rd, Kalkstein L. S. Synoptic weather modeling and estimates of the exposure-response relationship between daily mortality and particulate air pollution. Environ Health Perspect. 1996 Apr;104(4):414–420. doi: 10.1289/ehp.96104414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Pope C. A., 3rd, Thun M. J., Namboodiri M. M., Dockery D. W., Evans J. S., Speizer F. E., Heath C. W., Jr Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am J Respir Crit Care Med. 1995 Mar;151(3 Pt 1):669–674. doi: 10.1164/ajrccm/151.3_Pt_1.669. [DOI] [PubMed] [Google Scholar]
  48. Powell C. V., Nash A. A., Powers H. J., Primhak R. A. Antioxidant status in asthma. Pediatr Pulmonol. 1994 Jul;18(1):34–38. doi: 10.1002/ppul.1950180109. [DOI] [PubMed] [Google Scholar]
  49. Revesz R. L. Environmental regulation, cost-benefit analysis, and the discounting of human lives. Columbia Law Rev. 1999 May;99(4):941–1017. [PubMed] [Google Scholar]
  50. Ryan G., Knuiman M. W., Divitini M. L., James A., Musk A. W., Bartholomew H. C. Decline in lung function and mortality: the Busselton Health Study. J Epidemiol Community Health. 1999 Apr;53(4):230–234. doi: 10.1136/jech.53.4.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Schelegle E. S., Adams W. C., Siefkin A. D. Indomethacin pretreatment reduces ozone-induced pulmonary function decrements in human subjects. Am Rev Respir Dis. 1987 Dec;136(6):1350–1354. doi: 10.1164/ajrccm/136.6.1350. [DOI] [PubMed] [Google Scholar]
  52. Schwartz J. Air pollution and daily mortality: a review and meta analysis. Environ Res. 1994 Jan;64(1):36–52. doi: 10.1006/enrs.1994.1005. [DOI] [PubMed] [Google Scholar]
  53. Schwartz J. Air pollution and hospital admissions for cardiovascular disease in Tucson. Epidemiology. 1997 Jul;8(4):371–377. doi: 10.1097/00001648-199707000-00004. [DOI] [PubMed] [Google Scholar]
  54. Schwartz J. Air pollution and hospital admissions for heart disease in eight U.S. counties. Epidemiology. 1999 Jan;10(1):17–22. [PubMed] [Google Scholar]
  55. Schwartz J. Harvesting and long term exposure effects in the relation between air pollution and mortality. Am J Epidemiol. 2000 Mar 1;151(5):440–448. doi: 10.1093/oxfordjournals.aje.a010228. [DOI] [PubMed] [Google Scholar]
  56. Schwartz J., Morris R. Air pollution and hospital admissions for cardiovascular disease in Detroit, Michigan. Am J Epidemiol. 1995 Jul 1;142(1):23–35. doi: 10.1093/oxfordjournals.aje.a117541. [DOI] [PubMed] [Google Scholar]
  57. Schwartz J. Particulate air pollution and daily mortality in Detroit. Environ Res. 1991 Dec;56(2):204–213. doi: 10.1016/s0013-9351(05)80009-x. [DOI] [PubMed] [Google Scholar]
  58. Schünemann H. J., Dorn J., Grant B. J., Winkelstein W., Jr, Trevisan M. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest. 2000 Sep;118(3):656–664. doi: 10.1378/chest.118.3.656. [DOI] [PubMed] [Google Scholar]
  59. Seneff M. G., Wagner D. P., Wagner R. P., Zimmerman J. E., Knaus W. A. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA. 1995 Dec 20;274(23):1852–1857. [PubMed] [Google Scholar]
  60. Shumway R. H., Azari A. S., Pawitan Y. Modeling mortality fluctuations in Los Angeles as functions of pollution and weather effects. Environ Res. 1988 Apr;45(2):224–241. doi: 10.1016/s0013-9351(88)80049-5. [DOI] [PubMed] [Google Scholar]
  61. Spektor D. M., Lippmann M., Thurston G. D., Lioy P. J., Stecko J., O'Connor G., Garshick E., Speizer F. E., Hayes C. Effects of ambient ozone on respiratory function in healthy adults exercising outdoors. Am Rev Respir Dis. 1988 Oct;138(4):821–828. doi: 10.1164/ajrccm/138.4.821. [DOI] [PubMed] [Google Scholar]
  62. Thurston G. D. A critical review of PM10-mortality time-series studies. J Expo Anal Environ Epidemiol. 1996 Jan-Mar;6(1):3–21. [PubMed] [Google Scholar]
  63. Thurston G. D., Ito K. Epidemiological studies of acute ozone exposures and mortality. J Expo Anal Environ Epidemiol. 2001 Jul-Aug;11(4):286–294. doi: 10.1038/sj.jea.7500169. [DOI] [PubMed] [Google Scholar]
  64. Touloumi G., Katsouyanni K., Zmirou D., Schwartz J., Spix C., de Leon A. P., Tobias A., Quennel P., Rabczenko D., Bacharova L. Short-term effects of ambient oxidant exposure on mortality: a combined analysis within the APHEA project. Air Pollution and Health: a European Approach. Am J Epidemiol. 1997 Jul 15;146(2):177–185. doi: 10.1093/oxfordjournals.aje.a009249. [DOI] [PubMed] [Google Scholar]
  65. Tyler W. S., Tyler N. K., Last J. A., Gillespie M. J., Barstow T. J. Comparison of daily and seasonal exposures of young monkeys to ozone. Toxicology. 1988 Jul;50(2):131–144. doi: 10.1016/0300-483x(88)90086-8. [DOI] [PubMed] [Google Scholar]
  66. Weiss K. B., Sullivan S. D., Lyttle C. S. Trends in the cost of illness for asthma in the United States, 1985-1994. J Allergy Clin Immunol. 2000 Sep;106(3):493–499. doi: 10.1067/mai.2000.109426. [DOI] [PubMed] [Google Scholar]
  67. Ying R. L., Gross K. B., Terzo T. S., Eschenbacher W. L. Indomethacin does not inhibit the ozone-induced increase in bronchial responsiveness in human subjects. Am Rev Respir Dis. 1990 Oct;142(4):817–821. doi: 10.1164/ajrccm/142.4.817. [DOI] [PubMed] [Google Scholar]
  68. Zanobetti A., Schwartz J., Gold D. Are there sensitive subgroups for the effects of airborne particles? Environ Health Perspect. 2000 Sep;108(9):841–845. doi: 10.1289/ehp.00108841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Zemp E., Elsasser S., Schindler C., Künzli N., Perruchoud A. P., Domenighetti G., Medici T., Ackermann-Liebrich U., Leuenberger P., Monn C. Long-term ambient air pollution and respiratory symptoms in adults (SAPALDIA study). The SAPALDIA Team. Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1257–1266. doi: 10.1164/ajrccm.159.4.9807052. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES